US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

101.62

-2.3146-2.23%

Volume:9K

Turnover:872.46K

Market Cap:121.94M

PE:- -

High:104.53

Open:104.53

Low:100.91

Close:103.93

52wk High:110.05

52wk Low:68.05

Shares:1.20M

Float Shares:1.20M

Volume Ratio:1.92

T/O Rate:0.72%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

Alvotech to present at upcoming investor conferences in September

Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty

Roche receives FDA approval for companion diagnostic tests for Ziihera

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

RegenXBio reshapes board with new independent director

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes

BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program

Lakefront Biotherapeutics granted orphan drug designation for gamgertamig

Birikim Varlık Yönetim Sets First Coupon Rate on TLREF-Linked Financing Bill

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

Ichigo Hotel REIT Sets Rates on JPY 8.2 Billion in New Loans

If Rising Rates were Enough to End a Bull Market, We'd Have Entered a Bear Market Long Ago

Regeneron’s Pasatru granted FDA approval for FOP

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BBP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":101.6155,"timestamp":1789489951409,"preClose":103.9301,"halted":0,"volume":8613,"delay":0,"changeRate":-0.022270737736228473,"floatShares":1200004,"shares":1200004,"eps":0,"marketStatus":"Trading","change":-2.3146,"latestTime":"09-15 12:43:22 EDT","open":104.53,"high":104.53,"low":100.905,"amount":872462.27574,"amplitude":0.034879,"askPrice":102.57,"askSize":700,"bidPrice":101.2,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.9301,"sharesOutstanding":600004,"nav":103.362,"aum":124035301.07,"bidAskSpread":0.00263,"preHourTrading":{"tag":"盘前","latestPrice":103.9301,"preClose":103.9301,"latestTime":"07:02 EDT","volume":1,"amount":103.9301,"timestamp":1789470128746,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.9499,"preClose":103.9301,"latestTime":"19:30 EDT","volume":11,"amount":1143.2311,"timestamp":1789428605785,"change":0.0198,"changeRate":0.000191,"amplitude":0},"volumeRatio":1.923994,"impliedVol":0.2302,"impliedVolPercentile":0.502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1200004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.923994,"shares":1200004,"dividePrice":0,"high":104.53,"amplitude":0.034879,"preClose":103.9301,"low":100.905,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":101.6155,"committee":-0.997147,"eps":0,"divideRate":0,"volume":8613,"delay":0,"ttmEps":0,"open":104.53,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":106.7132,"twentyDayClose":102.7277,"sixtyDayClose":90.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148310736","title":"New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1148310736","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148310736?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:30","pubTimestamp":1788136244,"startTime":"0","endTime":"0","summary":"Based on the Hong Kong Stock Exchange disclosure on August 28, Betta Pharmaceuticals Co., Ltd. (300558.SZ) has submitted a listing application for the Main Board, with CITIC Securities acting as its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","300558","MRNX","03069","IPOS","MRNY","BBP","BK0239","IBBQ","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","PINK","LFSC","BK4139","NVIB","TECB","IEIH","BMED","BBP","BK4585","PSCH","RSPH","SYNB","TBXU","BK4588","IBB","MRNX","GNMX","IDNA","IYH","XLVX","BK4007","MEDI","PTGX","FRTY","TAK","GDOC","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","NVIB","PSCH","MRNX","BBP","TECB","BMED","BK4588","GNMX","LABU","IBB","SYNB","MRNY","RSPH","XLVX","IDNA","BK4585","FRTY","PINK","GDOC","MEDI","IYH","IEIH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","NVIB","SYNB","BMED","GDOC","LFSC","TECB","IYH","PINK","GNMX","FRTY","IBB","RSPH","BBP","PSCH","MRNY","TBXU","MRNX","TAK","BK4007","BK4585","MEDI","IDNA","LABU","IEIH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065799","title":"PYC Therapeutics Files 2026 Corporate Governance Statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065799?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:28","pubTimestamp":1787909297,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an update. PYC Therapeutics Limited is an Australia-listed biotechnology company that disclose...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","JDOC","FHLC","BK4139","SYNB","RSPH","FWD","BK4007","DARP","BK4585","IBB","LNGR","XT","BBP","BK4539","AGNG","IEIH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085616","title":"Alvotech to present at upcoming investor conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085616","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662085616?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832000,"startTime":"0","endTime":"0","summary":"REYKJAVIK, Iceland, Aug.  27, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for pat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351931/0/en/alvotech-to-present-at-upcoming-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662872226","title":"Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2662872226","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662872226?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:37","pubTimestamp":1787801870,"startTime":"0","endTime":"0","summary":"Biotron ( ($AU:BIT) ) has shared an announcement. Biotron Limited, an ASX-listed Australian biotechnology company, focuses on antiviral drug develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biotron-posts-wider-annual-loss-but-boosts-asset-backing-amid-material-uncertainty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biotron-posts-wider-annual-loss-but-boosts-asset-backing-amid-material-uncertainty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","DARP","JDOC","RSPH","SYNB","FHLC","XT","BBP","IBB","IEIH","LNGR","FWD","BK4585","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","BK4007","GDOC","PINK","RHHBY","BK4585","FRTY","LFSC","NVIB","MEDI","XLVX","IYH","CANC","BMED","IBB","TECB","LABU","IEIH","PSCH","HRTS","MRNY","RSPH","IDNA","SYNB","TBXU","BK4588","MRNX","BBP","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","LU0889565916.HKD","GDOC","MRNY","SYNB","PTH","IE00BFTCPJ56.SGD","LABU","LU0320765992.SGD","NVIB","PINK","BMED","TECB","BBH","XLVX","IEIH","TBXU","CANC","IE0002141913.USD","IYH","MEDI","IE00B4R5TH58.HKD","BBP","IBB","PSCH","LFSC","LU0109394709.USD","BK4139","IE0009355771.USD","BK4585","BK4588","FRTY","RVMD","IE00B2B36J28.USD","IDNA","IE00BJJMRZ35.SGD","GNMX","MRNX","IE00BJT1NW94.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","FRTY","PINK","RSPH","IYH","MRNY","TBXU","BBH","BK4588","PSCH","BK4585","IDNA","TECB","IEIH","SYNB","LFSC","BK4139","IE00BJT1NW94.SGD","PTH","IE0009354923.USD","LU0320765992.SGD","BBP","MEDI","LABU","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0009355771.USD","GDOC","XLVX","MRNX","IE0002141913.USD","LU0109394709.USD","NVIB","IE00B4R5TH58.HKD","RVMD","IE00B2B36J28.USD","BMED","CANC","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662313757","title":"RegenXBio reshapes board with new independent director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662313757","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662313757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:17","pubTimestamp":1787692674,"startTime":"0","endTime":"0","summary":"RegenXBio ( ($RGNX) ) has provided an announcement. On August 25, 2026, REGENXBIO Inc. appointed biotechnology investor Greg Ciongoli to its Board ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regenxbio-reshapes-board-with-new-independent-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regenxbio-reshapes-board-with-new-independent-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4585","IEIH","AGNG","IBB","SYNB","FHLC","DARP","RSPH","JDOC","XT","FWD","LNGR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","MRNY","LFSC","LABU","PSCH","NVIB","IEIH","MRNX","XLVX","BBP","BK4585","GNMX","PINK","BK4526","GDOC","SYNB","IBB","RSPH","IDNA","TBXU","TECB","IYH","BK4588","MEDI","BK4139","ONC","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662578669","title":"Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662578669","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662578669?lang=en_us&edition=fundamental","pubTime":"2026-08-25 13:27","pubTimestamp":1787635670,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Terragen Holdings Ltd ( ($AU:TGH) ). Terragen Holdings Limited, an agricultural biotechnology company, develops...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/terragen-posts-wider-loss-as-revenue-falls-and-asset-backing-erodes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/terragen-posts-wider-loss-as-revenue-falls-and-asset-backing-erodes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","JDOC","RSPH","AGNG","IBB","IVEG","BK4585","BBP","XT","DARP","FWD","LNGR","BK4588","IEIH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662404204","title":"BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662404204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662404204?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:02","pubTimestamp":1787616148,"startTime":"0","endTime":"0","summary":"BetterLife Pharma ( ($TSE:BETR) ) has issued an update. BetterLife Pharma Inc., a Vancouver-based biotechnology company, is focused on developing B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/betterlife-pharma-plans-equity-offering-to-advance-neurological-trial-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/betterlife-pharma-plans-equity-offering-to-advance-neurological-trial-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AGNG","BBP","SYNB","LNGR","IEIH","BK4585","RSPH","XT","FHLC","FWD","EQR","BK4215","REZ","JDOC","DARP","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206528","title":"Lakefront Biotherapeutics granted orphan drug designation for gamgertamig","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206528","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206528?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602240,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutic (LKFT) announced that the FDA has granted orphan drug designation to gamgertamig for the treatment of pemphigus. Gamgertam...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BBP","BK4139","LABU","LKFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661929195","title":"Birikim Varlık Yönetim Sets First Coupon Rate on TLREF-Linked Financing Bill","url":"https://stock-news.laohu8.com/highlight/detail?id=2661929195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661929195?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:47","pubTimestamp":1787327249,"startTime":"0","endTime":"0","summary":"Birikim Varlik Yonetim A.S. ( ($TR:BRKVY) ) just unveiled an update. Birikim Varlık Yönetim A.Ş. has disclosed the interest rates for the first cou...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/birikim-varlik-yonetim-sets-first-coupon-rate-on-tlref-linked-financing-bill?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/birikim-varlik-yonetim-sets-first-coupon-rate-on-tlref-linked-financing-bill?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAOS","BBP","CGDV","FXL","KOMP","TSDD","TSLW","TSLL","TSLQ","TSLT","UCC","VAW","TEST","07366","BK4588","09366","IJK","PEVC","AVSD","TSL","TSLO","TSLR","BK4585","ELOL","TSLP","TSLS","TSLY","TLA","TESL","RJZ","TSII","TSLI","LRCY","07766","FXR","CRSH","DFUV","CLIX","TSLG","TESC","TSLZ","ANEW","09766","TSYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","XT","IBBQ","LU0889565916.HKD","RSPH","FWD","SYNB","LU0109394709.USD","IEIH","BK4139","LU2106854487.HKD","BK4588","AGNG","LU2468319806.SGD","DARP","IBB","LNGR","LU0289739699.SGD","REGN","LU2237438978.USD","BK4585","BBP","TBXU","LU1974910355.USD","LU0823416689.USD","LU0114720955.EUR","LU2089984988.USD","LU0320765992.SGD","JDOC","BBH","LU2362541273.HKD","FHLC","LU1917777945.USD","LU0823434740.USD","LU0053666078.USD","LU0823434583.USD","LU0882574055.USD","LU2362540622.SGD","LU2362541513.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661125053","title":"Ichigo Hotel REIT Sets Rates on JPY 8.2 Billion in New Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2661125053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661125053?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:53","pubTimestamp":1787295222,"startTime":"0","endTime":"0","summary":"Ichigo Hotel REIT Investment Corp. ( ($JP:3463) ) has shared an update. Ichigo Hotel REIT Investment Corporation has set initial interest rates on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ichigo-hotel-reit-sets-rates-on-jpy-8-2-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ichigo-hotel-reit-sets-rates-on-jpy-8-2-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGDV","TESL","RJZ","JPY","CRSH","ELOL","FXL","TEST","CLIX","TESC","TSII","TSLP","UCC","PEVC","MDIV","REIT","PSCF","DFRA","TSLO","TSYY","TSLS","KOMP","CAOS","LRCY","RNTY","VAW","IQRA","07366","TSLY","AVSD","TSLG","FXR","IVRA","YLDW","DFUV","TSL","TLA","TSLT","TSLW","TSLZ","TSLQ","BPRE","TSLI","TSLL","ANEW","TSLR","RJMG","TSDD","IJK","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661392262","title":"If Rising Rates were Enough to End a Bull Market, We'd Have Entered a Bear Market Long Ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2661392262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661392262?lang=en_us&edition=fundamental","pubTime":"2026-08-21 02:03","pubTimestamp":1787248980,"startTime":"0","endTime":"0","summary":"MW If rising rates were enough to end a bull market, we'd have entered a bear market long agoMark HulbertThe 'Fed Model' has turned bearish - should you care?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLTW","GOVT","FXR","US2Y.BOND","US12M.BOND","IEI","RJZ","CLIX","US7Y.BOND","VGIT","DFUV","KOMP","SKRE","TSLP","CAOS","US30Y.BOND","US5Y.BOND","VAW","UDN","VGSH","UUP","UCC","KBE","MINT","US10Y.BOND","VGFPF","LRCY","UBT","AVSD","PEVC","SHY","SHV","ANEW","IJK","MUB","US3Y.BOND","US6M.BOND","FXL","HYG","BOXX","BBP","FAZ","BIL","CGDV","LQD","SCHO","TBT","TMF","BND","AGG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","TBXU","GNMX","XLVX","NVIB","RSPH","GDOC","IDNA","BK4585","LFSC","PSCH","SYNB","TECB","BMED","IYH","BBP","LABU","FRTY","MEDI","MRNY","IBB","IEIH","PINK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":3,"totalSize":162,"code":"91000000","status":"200"}]}}